Day: July 7, 2026

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

Nprepared by Vivaniovo Nordisk will conduct a non-exclusive internal evaluation of semaglutide implants ALAMEDA, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, biopharmaceutical company developing novel, ultra long-acting drug implants,

Read More

Better Roads Reduce Travel Time and Costs, Says PM

Kampong cham: Prime Minister Samdech Moha Borvor Thipadei Hun Manet has underscored that quality road infrastructure helps reduce travel time and transportation costs while boosting investment and economic growth. The Cambodian Premier made the remark…

Read More